Some bioinformatics analyses have proved that ANKZF1 based genes signature can predict the prognosis of patients with colon cancer, renal cell carcinoma, and prostate cancer (14, 29–33). Here, ANKZF1 is linked to hereditary clear cell renal cell carcinoma.